AR230730A1 - Procedimiento para preparar una suspension acuosa de oxendolona - Google Patents

Procedimiento para preparar una suspension acuosa de oxendolona

Info

Publication number
AR230730A1
AR230730A1 AR290244A AR29024482A AR230730A1 AR 230730 A1 AR230730 A1 AR 230730A1 AR 290244 A AR290244 A AR 290244A AR 29024482 A AR29024482 A AR 29024482A AR 230730 A1 AR230730 A1 AR 230730A1
Authority
AR
Argentina
Prior art keywords
oxendolone
preparing
procedure
water suspension
suspension
Prior art date
Application number
AR290244A
Other languages
English (en)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of AR230730A1 publication Critical patent/AR230730A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
AR290244A 1981-08-18 1982-08-06 Procedimiento para preparar una suspension acuosa de oxendolona AR230730A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56129517A JPS5832899A (ja) 1981-08-18 1981-08-18 オキセンドロン水性懸濁剤

Publications (1)

Publication Number Publication Date
AR230730A1 true AR230730A1 (es) 1984-06-29

Family

ID=15011450

Family Applications (1)

Application Number Title Priority Date Filing Date
AR290244A AR230730A1 (es) 1981-08-18 1982-08-06 Procedimiento para preparar una suspension acuosa de oxendolona

Country Status (13)

Country Link
US (1) US4462996A (es)
EP (1) EP0072662B1 (es)
JP (1) JPS5832899A (es)
KR (1) KR880001806B1 (es)
AR (1) AR230730A1 (es)
CA (1) CA1176983A (es)
DE (1) DE3263754D1 (es)
ES (1) ES515057A0 (es)
GR (1) GR76258B (es)
HK (1) HK23888A (es)
MY (1) MY8700654A (es)
PT (1) PT75435B (es)
SG (1) SG110187G (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4120311A1 (de) * 1991-06-20 1992-12-24 Kali Chemie Pharma Gmbh Konservierte pharmazeutische zubereitungen
US20050032811A1 (en) * 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
ATE411797T2 (de) * 2003-10-23 2008-11-15 Otsuka Pharma Co Ltd Sterile injizierbare aripiprazol-formulierung mit kontrollierter freisetzung und verfahren
EP1933814A2 (en) * 2005-09-15 2008-06-25 Elan Pharma International Limited Nanoparticulate aripiprazole formulations
NZ582415A (en) * 2007-07-31 2012-05-25 Otsuka Pharma Co Ltd Methods for producing aripiprazole suspension and freeze-dried formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2861920A (en) * 1954-05-04 1958-11-25 Upjohn Co Therapeutic suspensions of steroids containing pvp and/or pva
US3856829A (en) * 1970-01-07 1974-12-24 Takeda Chemical Industries Ltd 16{62 -hydrocarbon substituted estrane compounds
JPS4832643A (es) * 1971-09-02 1973-05-01
JPS4966815A (es) * 1972-10-25 1974-06-28

Also Published As

Publication number Publication date
CA1176983A (en) 1984-10-30
SG110187G (en) 1988-05-20
JPS5832899A (ja) 1983-02-25
HK23888A (en) 1988-04-08
GR76258B (es) 1984-08-04
DE3263754D1 (en) 1985-06-27
ES8403719A1 (es) 1984-04-01
MY8700654A (en) 1987-12-31
ES515057A0 (es) 1984-04-01
KR840000901A (ko) 1984-03-26
US4462996A (en) 1984-07-31
EP0072662A2 (en) 1983-02-23
JPS6361957B2 (es) 1988-11-30
EP0072662A3 (en) 1983-08-24
PT75435B (pt) 1985-05-31
KR880001806B1 (ko) 1988-09-19
PT75435A (pt) 1982-09-01
EP0072662B1 (en) 1985-05-22

Similar Documents

Publication Publication Date Title
ES539563A0 (es) Un procedimiento para preparar derivados de fenilamino-mer- captoimidazol
ES519031A0 (es) Un procedimiento para preparar derivados de fenilciclobutano.
ES518276A0 (es) Un procedimiento para preparar nuevos derivados de tienopirimidina.
ES529349A0 (es) Un procedimiento para la preparacion de derivados de acilmorfinano
ES525886A0 (es) Un procedimiento para preparar derivados de propinilaminoisoxazol
DK284888D0 (da) Fremgangsmaade til fremstilling af en vandig suspension af anitrificerende bakterier
ES539000A0 (es) Un procedimiento para preparar un derivado de una enzima fibronolitica
ES524922A0 (es) Un procedimiento para la preparacion de nuevos derivados de 3-amino-pregn-5-eno
MX7466E (es) Procedimiento para preparar una composicion surfactante de almidon
ES512852A0 (es) "un procedimiento para preparar nuevos derivados de la n-dihidrotiazolil-3-quinolein-carboxamida".
MX7528E (es) Procedimiento para la preparacion de una vacuna sintetica
ES546061A0 (es) Un procedimiento para preparar un derivado de uridina
ES552910A0 (es) Un procedimiento para preparar derivados de indol
ES537349A0 (es) Un procedimiento para la preparacion de un aminotiol cuaternario
BR8202085A (pt) Processo para a preparacao de derivados de piperazina
ES527795A0 (es) Un procedimiento para preparar derivados de propinilaminotiazol
AR230730A1 (es) Procedimiento para preparar una suspension acuosa de oxendolona
RO85387A (ro) Procedeu de preparare a stereospecifica a 5-fenil-2s-pentanolului
MX7600E (es) Procedimiento para elaborar alcanoles
ES518347A0 (es) Un procedimiento para la preparacion de derivados de desoxiuridina
ES526149A0 (es) Un procedimiento para la preparacion de derivados de espirotiazolidinil-piperazina
ES546574A0 (es) Procedimiento para preparar derivados de saframicina a
ES528985A0 (es) Un procedimiento para la preparacion de una b- lactama
ES537098A0 (es) Un procedimiento para preparar derivados de tiadiazina
ES526647A0 (es) Metodo de preparar derivados de p-acilaminofenol